Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hanson

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Pharmacology & Therapeutics|June 1, 2022
Superconserved receptors expressed in the brain: Expression, function, motifs and evolution of an orphan receptor familyClaudia Stäubert, Monika Wozniak, Nadine Dupuis, et al.
Biochemical Pharmacology|September 20, 2015
Forskolin-free cAMP assay for Gi-coupled receptorsJulie Gilissen, Pierre Geubelle, Nadine Dupuis, et al.
Memory & Cognition|August 8, 2025
Popular music and movies as autobiographical memory cuesJulien Hanson, Jessica Frame, Elena Bai, et al.
Biochemical Pharmacology|May 31, 2016
Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7Martyna Szpakowska, Nadine Dupuis, Alessandra Baragli, et al.
Biochemical Pharmacology|March 14, 2018
Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonistsMartyna Szpakowska, Max Meyrath, Nathan Reynders, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
New developments on thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
Progress in the field of GPIIb/IIIa antagonistsJulien Hanson, Xavier de Leval, Jean-Louis David, et al.
Current Medicinal Chemistry|May 12, 2004
New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulatorsXavier de Leval, Julien Hanson, Jean-Louis David, et al.
Journal of Medicinal Chemistry|July 17, 2007
Design, synthesis, and SAR study of a series of N-alkyl-N'-[2-(aryloxy)-5-nitrobenzenesulfonyl]ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptorJulien Hanson, Jean-Michel Dogné, Jérémie Ghiotto, et al.
Pharmacology Research & Perspectives|January 28, 2021
β-arrestin2 recruitment at the β2 adrenergic receptor: A luciferase complementation assay adapted for undergraduate training in pharmacologyMattia Ferraiolo, Pauline Beckers, Nicolas Marquet, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Pharmacology & Therapeutics|June 1, 2022
Superconserved receptors expressed in the brain: Expression, function, motifs and evolution of an orphan receptor familyClaudia Stäubert, Monika Wozniak, Nadine Dupuis, et al.
Biochemical Pharmacology|September 20, 2015
Forskolin-free cAMP assay for Gi-coupled receptorsJulie Gilissen, Pierre Geubelle, Nadine Dupuis, et al.
Memory & Cognition|August 8, 2025
Popular music and movies as autobiographical memory cuesJulien Hanson, Jessica Frame, Elena Bai, et al.
Biochemical Pharmacology|May 31, 2016
Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7Martyna Szpakowska, Nadine Dupuis, Alessandra Baragli, et al.
Biochemical Pharmacology|March 14, 2018
Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonistsMartyna Szpakowska, Max Meyrath, Nathan Reynders, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
New developments on thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
Progress in the field of GPIIb/IIIa antagonistsJulien Hanson, Xavier de Leval, Jean-Louis David, et al.
Current Medicinal Chemistry|May 12, 2004
New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulatorsXavier de Leval, Julien Hanson, Jean-Louis David, et al.
Journal of Medicinal Chemistry|July 17, 2007
Design, synthesis, and SAR study of a series of N-alkyl-N'-[2-(aryloxy)-5-nitrobenzenesulfonyl]ureas and -cyanoguanidine as selective antagonists of the TPalpha and TPbeta isoforms of the human thromboxane A2 receptorJulien Hanson, Jean-Michel Dogné, Jérémie Ghiotto, et al.
Pharmacology Research & Perspectives|January 28, 2021
β-arrestin2 recruitment at the β2 adrenergic receptor: A luciferase complementation assay adapted for undergraduate training in pharmacologyMattia Ferraiolo, Pauline Beckers, Nicolas Marquet, et al.
Pageof 7